Characterization of Structurally Distinct, Isoform-Selective Phosphoinositide 3'-Kinase Inhibitors in Combination With Radiation in the Treatment of Glioblastoma

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-07-0393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Phosphoinositide 3-Kinase Inhibitors in Lymphoma

Current Opinion in Oncology
Cancer ResearchOncology
2014English

Characterization of GSK′963: A Structurally Distinct, Potent and Selective Inhibitor of RIP1 Kinase

Cell Death Discovery
Cancer ResearchMolecular NeuroscienceImmunologyCell BiologyCellular
2015English

Furan-2-Ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase G

English

Development of Selective Covalent Janus Kinase 3 Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Identification of IGF2 Signaling Through Phosphoinositide-3-Kinase Regulatory Subunit 3 as a Growth-Promoting Axis in Glioblastoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2007English

Characterization of Two Distinct Structural Classes of Selective Aldehyde Dehydrogenase 1A1 Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Development of an ELISA-Based HDAC Activity Assay for Characterization of Isoform-Selective Inhibitors

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2015English

Phosphoinositide 3-Kinase-Δ (PI3Kδ); Phosphoinositide 3-Kinase Catalytic Subunit Δ-Polypeptide (PI3KCD; P110δ)

Science-Business eXchange
2014English

Targeting the Phosphoinositide 3-Kinase P110- Isoform Impairs Cell Proliferation, Survival, and Tumor Growth in Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy